• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗线粒体DNA疾病的实验策略。

Experimental strategies towards treating mitochondrial DNA disorders.

作者信息

Gardner Julie L, Craven Lyndsey, Turnbull Douglass M, Taylor Robert W

机构信息

Mitochondrial Research Group, School of Neurology, Neurobiology and Psychiatry, The Medical School, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.

出版信息

Biosci Rep. 2007 Jun;27(1-3):139-50. doi: 10.1007/s10540-007-9042-3.

DOI:10.1007/s10540-007-9042-3
PMID:17492502
Abstract

An extensive range of molecular defects have been identified in the human mitochondrial genome (mtDNA), causing a range of clinical phenotypes characterized by mitochondrial respiratory chain dysfunction. Sadly, given the complexities of mitochondrial genetics, there are no available cures for mtDNA disorders. In this review, we consider experimental, genetic-based strategies that have been or are being explored towards developing treatments, focussing on two specific areas which we are actively pursuing--assessing the benefit of exercise training for patients with mtDNA defects, and the prevention of mtDNA disease transmission.

摘要

人类线粒体基因组(mtDNA)中已发现广泛的分子缺陷,这些缺陷导致一系列以线粒体呼吸链功能障碍为特征的临床表型。遗憾的是,鉴于线粒体遗传学的复杂性,目前尚无治疗线粒体DNA疾病的方法。在这篇综述中,我们考虑了已经或正在探索的基于实验和遗传学的治疗策略,重点关注我们正在积极研究的两个特定领域——评估运动训练对线粒体DNA缺陷患者的益处,以及预防线粒体DNA疾病的传播。

相似文献

1
Experimental strategies towards treating mitochondrial DNA disorders.治疗线粒体DNA疾病的实验策略。
Biosci Rep. 2007 Jun;27(1-3):139-50. doi: 10.1007/s10540-007-9042-3.
2
Strategies for treating disorders of the mitochondrial genome.线粒体基因组疾病的治疗策略。
Biochim Biophys Acta. 2004 Dec 6;1659(2-3):232-9. doi: 10.1016/j.bbabio.2004.09.003.
3
Mitochondrial genetic medicine.线粒体遗传医学。
Nat Genet. 2018 Dec;50(12):1642-1649. doi: 10.1038/s41588-018-0264-z. Epub 2018 Oct 29.
4
Gene therapy for the treatment of mitochondrial DNA disorders.用于治疗线粒体DNA疾病的基因疗法。
Expert Opin Biol Ther. 2005 Feb;5(2):183-94. doi: 10.1517/14712598.5.2.183.
5
Keep the fire burning: Current avenues in the quest of treating mitochondrial disorders.让希望之火继续燃烧:治疗线粒体疾病的当前研究途径
Mitochondrion. 2015 Sep;24:32-49. doi: 10.1016/j.mito.2015.06.002. Epub 2015 Jun 30.
6
New approaches to the treatment of mitochondrial disorders.线粒体疾病治疗的新方法。
Reprod Biomed Online. 2004 Jan;8(1):16-23. doi: 10.1016/s1472-6483(10)60494-4.
7
Mitochondrial replacement: from basic research to assisted reproductive technology portfolio tool-technicalities and possible risks.线粒体替代:从基础研究到辅助生殖技术组合工具——技术细节与潜在风险
Mol Hum Reprod. 2015 Jan;21(1):3-10. doi: 10.1093/molehr/gau082. Epub 2014 Nov 24.
8
Development of mitochondrial gene replacement therapy.线粒体基因替代疗法的发展。
J Bioenerg Biomembr. 2004 Aug;36(4):387-93. doi: 10.1023/B:JOBB.0000041773.20072.9e.
9
Mitochondrial diseases: therapeutic approaches.线粒体疾病:治疗方法。
Biosci Rep. 2007 Jun;27(1-3):125-37. doi: 10.1007/s10540-007-9041-4.
10
[MITO-Porter; a cutting-edge technology for mitochondrial gene therapy].[线粒体载体;一种用于线粒体基因治疗的前沿技术]
Yakugaku Zasshi. 2012;132(12):1389-98. doi: 10.1248/yakushi.12-00235-3.

引用本文的文献

1
Biodiversity time series are biased towards increasing species richness in changing environments.生物多样性时间序列在变化的环境中偏向于增加物种丰富度。
Nat Ecol Evol. 2023 Jul;7(7):994-1001. doi: 10.1038/s41559-023-02078-w. Epub 2023 Jun 5.
2
Creation of Mitochondrial Disease Models Using Mitochondrial DNA Editing.利用线粒体DNA编辑创建线粒体疾病模型
Biomedicines. 2023 Feb 12;11(2):532. doi: 10.3390/biomedicines11020532.
3
Current advances in gene therapy of mitochondrial diseases.线粒体疾病的基因治疗新进展。
J Transl Med. 2022 Dec 5;20(1):562. doi: 10.1186/s12967-022-03685-0.
4
Mitochondrial mutations alter endurance exercise response and determinants in mice.线粒体突变改变了小鼠的耐力运动反应和决定因素。
Proc Natl Acad Sci U S A. 2022 May 3;119(18):e2200549119. doi: 10.1073/pnas.2200549119. Epub 2022 Apr 28.
5
The possible involvement of mitochondrial dysfunctions in Lewy body dementia: a systematic review.线粒体功能障碍在路易体痴呆中的可能作用:一项系统综述。
Funct Neurol. 2015 Jul-Sep;30(3):151-8. doi: 10.11138/fneur/2015.30.3.151.
6
MitoTALEN: A General Approach to Reduce Mutant mtDNA Loads and Restore Oxidative Phosphorylation Function in Mitochondrial Diseases.线粒体转录激活样效应因子核酸酶(MitoTALEN):一种降低线粒体疾病中突变型线粒体DNA负荷并恢复氧化磷酸化功能的通用方法。
Mol Ther. 2015 Oct;23(10):1592-9. doi: 10.1038/mt.2015.126. Epub 2015 Jul 10.
7
The use of mitochondria-targeted endonucleases to manipulate mtDNA.使用线粒体靶向核酸内切酶来操纵线粒体DNA。
Methods Enzymol. 2014;547:373-97. doi: 10.1016/B978-0-12-801415-8.00018-7.
8
Genetic influences on brain developmental trajectories on neuroimaging studies: from infancy to young adulthood.神经影像学研究中基因对大脑发育轨迹的影响:从婴儿期到青年期
Brain Imaging Behav. 2014 Jun;8(2):234-50. doi: 10.1007/s11682-013-9260-1.
9
Organ-specific shifts in mtDNA heteroplasmy following systemic delivery of a mitochondria-targeted restriction endonuclease.线粒体靶向限制性内切酶全身给药后 mtDNA 异质性的组织特异性改变。
Gene Ther. 2010 Jun;17(6):713-20. doi: 10.1038/gt.2010.25. Epub 2010 Mar 11.
10
How can we treat mitochondrial encephalomyopathies? Approaches to therapy.我们如何治疗线粒体脑肌病?治疗方法。
Neurotherapeutics. 2008 Oct;5(4):558-68. doi: 10.1016/j.nurt.2008.07.002.